Skip to main content
Back
Watch Compare

SELECTIS HEALTH, INC.

Data quality: 100%
GBCS
OTC Financial Services Holding & Investment Offices
$4.35
$0.00 (0.00%)
Mkt Cap: 13.34 M
Price
$4.35
Mkt Cap
13.34 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Revenue grew 17.20% annually over 5 years — strong growth
Generating 417,875.0 in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 9.84%
Capital efficient — spends only 0.94% of revenue on capex

Growth

Revenue Growth (5Y)
17.20%
Above sector avg (5.83%)
Revenue (1Y)7.36%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
N/A
ROIC-7.89%
Net Margin-1.87%
Op. Margin-3.00%

Safety

Debt / Equity
N/A
Current Ratio0.19
Interest Coverage-0.42

Valuation

PE (TTM)
-16.93
Below sector avg (11.15)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Financial Services sector median (2180 peers)
Metric Stock Sector Median
P/E -16.9 11.1
P/B — 1.2
ROE % — 9.2
Net Margin % -1.9 9.4
Rev Growth 5Y % 17.2 5.8
D/E — 0.5

Analyst Price Target

No analyst coverage available

Earnings Estimates

No forward estimates available

Earnings Surprises

Last 1 quarter
Quarter Est. EPS Actual EPS Surprise
Q12010 N/A $0.04 —

All Fundamental Metrics
Growth
Revenue Growth (1Y) 7.36% Revenue Growth (3Y) -1.37%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 17.20% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 42.17 M Net Income (TTM) -788,094.0
ROE N/A ROA -2.36%
Gross Margin N/A Operating Margin -3.00%
Net Margin -1.87% Free Cash Flow (TTM) 417,875.0
ROIC -7.89% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.19
Interest Coverage -0.42 Asset Turnover 1.26
Working Capital -16.34 M Tangible Book Value -6.73 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -16.93 Forward P/E N/A
P/B Ratio N/A P/S Ratio 0.32
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 3.13%
Market Cap 13.34 M Enterprise Value 31.44 M
Per Share
EPS (Diluted TTM) -0.28 Revenue / Share 13.75
FCF / Share 0.14 OCF / Share 0.27
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0.94% FCF Conversion -53.02%
SBC-Adj. FCF N/A Growth Momentum -9.84

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue 39.49 M 36.78 M 40.60 M 29.29 M 20.93 M
Net Income -2.42 M -3.97 M -2.40 M -2.25 M 2.96 M
EPS (Diluted) -0.80 -1.31 -0.79 -0.82 0.11
Gross Profit — — — — —
Operating Income -2.73 M -8.96 M -286,572.0 -728,992.0 3.37 M
EBITDA — — — — —
R&D Expenses — — — — —
SG&A Expenses — — — — —
D&A 1.57 M 1.67 M 1.79 M 1.73 M 1.58 M
Interest Expense 2.05 M 2.17 M 2.23 M 2.50 M 2.14 M
Income Tax — — — — —

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 33.45 M 40.67 M 42.49 M 46.92 M 45.93 M
Total Liabilities 38.86 M 43.64 M 41.54 M 43.82 M 42.72 M
Shareholders' Equity -5.41 M -2.96 M 952,835.0 3.10 M 3.41 M
Total Debt 19.13 M 25.18 M 34.40 M 6.31 M 39.25 M
Cash & Equivalents 680,332.0 1.48 M 1.42 M 3.94 M 3.57 M
Current Assets 3.53 M 4.96 M 4.96 M 7.97 M —
Current Liabilities 19.63 M 18.15 M 6.85 M 11.79 M —